| 1 | once | 10,888 |
| 2 | pd-0299685 | 8 |
| 3 | rtifngamma | 7 |
| 4 | bid-based | 5 |
| 5 | zo-20 | 4 |
| 6 | 187,000 | 3 |
| 7 | binazine | 3 |
| 8 | methandrostenolone | 3 |
| 9 | county-specific | 2 |
| 10 | evasin-4 | 2 |
| 11 | intra-cervically | 2 |
| 12 | myomycin | 2 |
| 13 | nurse-generated | 2 |
| 14 | soflens | 2 |
| 15 | 0.063ng/ml | 1 |
| 16 | 0.19µg/ml | 1 |
| 17 | 0.4+/-1.4 | 1 |
| 18 | 0.698g/kg | 1 |
| 19 | 117/year | 1 |
| 20 | 12,485 | 1 |
| 21 | 128-fold | 1 |
| 22 | 187-fold | 1 |
| 23 | 2.5ata | 1 |
| 24 | 20lmg | 1 |
| 25 | 4.8g | 1 |
| 26 | 4.9+/-7.3 | 1 |
| 27 | 40/10mg | 1 |
| 28 | 50,000/µl | 1 |
| 29 | 500-1000mg | 1 |
| 30 | 80,000/µl | 1 |
| 31 | adminitered | 1 |
| 32 | alfa/m2 | 1 |
| 33 | anally | 1 |
| 34 | asprellanoside | 1 |
| 35 | bathroom-related | 1 |
| 36 | beta-carotene/d | 1 |
| 37 | bid-treated | 1 |
| 38 | bolus/0.5-microg/kg | 1 |
| 39 | bolus/0.75-microg/kg | 1 |
| 40 | call-ins | 1 |
| 41 | daily-once | 1 |
| 42 | dentifrice/dental | 1 |
| 43 | distance-is | 1 |
| 44 | dm-/chd-as | 1 |
| 45 | frames- | 1 |
| 46 | micron/kg | 1 |
| 47 | nanorod-based | 1 |
| 48 | nevirapine–zidovudine–lamivudine | 1 |
| 49 | non-strenuous | 1 |
| 50 | pegylated-ifnα2a | 1 |
| 51 | phasically | 1 |
| 52 | polyphenol-content | 1 |
| 53 | q4w-treated | 1 |
| 54 | rebandaged | 1 |
| 55 | rich-foods | 1 |
| 56 | rosuvastatin/day | 1 |
| 57 | sixin | 1 |
| 58 | trimethoprim/sulphadiazine/kgbw/day | 1 |
| 59 | tshre/l | 1 |
| 60 | weekly+placebo-iv | 1 |
| 61 | work/school/other | 1 |
| 62 | €199/heifer | 1 |
| 63 | ≥0.79 | 1 |
| 1 | 0.063ng/ml | 1 |
| 2 | 0.19µg/ml | 1 |
| 3 | 0.4+/-1.4 | 1 |
| 4 | 0.698g/kg | 1 |
| 5 | 117/year | 1 |
| 6 | 12,485 | 1 |
| 7 | 128-fold | 1 |
| 8 | 187,000 | 3 |
| 9 | 187-fold | 1 |
| 10 | 2.5ata | 1 |
| 11 | 20lmg | 1 |
| 12 | 4.8g | 1 |
| 13 | 4.9+/-7.3 | 1 |
| 14 | 40/10mg | 1 |
| 15 | 50,000/µl | 1 |
| 16 | 500-1000mg | 1 |
| 17 | 80,000/µl | 1 |
| 18 | adminitered | 1 |
| 19 | alfa/m2 | 1 |
| 20 | anally | 1 |
| 21 | asprellanoside | 1 |
| 22 | bathroom-related | 1 |
| 23 | beta-carotene/d | 1 |
| 24 | bid-based | 5 |
| 25 | bid-treated | 1 |
| 26 | binazine | 3 |
| 27 | bolus/0.5-microg/kg | 1 |
| 28 | bolus/0.75-microg/kg | 1 |
| 29 | call-ins | 1 |
| 30 | county-specific | 2 |
| 31 | daily-once | 1 |
| 32 | dentifrice/dental | 1 |
| 33 | distance-is | 1 |
| 34 | dm-/chd-as | 1 |
| 35 | evasin-4 | 2 |
| 36 | frames- | 1 |
| 37 | intra-cervically | 2 |
| 38 | methandrostenolone | 3 |
| 39 | micron/kg | 1 |
| 40 | myomycin | 2 |
| 41 | nanorod-based | 1 |
| 42 | nevirapine–zidovudine–lamivudine | 1 |
| 43 | non-strenuous | 1 |
| 44 | nurse-generated | 2 |
| 45 | once | 10,888 |
| 46 | pd-0299685 | 8 |
| 47 | pegylated-ifnα2a | 1 |
| 48 | phasically | 1 |
| 49 | polyphenol-content | 1 |
| 50 | q4w-treated | 1 |
| 51 | rebandaged | 1 |
| 52 | rich-foods | 1 |
| 53 | rosuvastatin/day | 1 |
| 54 | rtifngamma | 7 |
| 55 | sixin | 1 |
| 56 | soflens | 2 |
| 57 | trimethoprim/sulphadiazine/kgbw/day | 1 |
| 58 | tshre/l | 1 |
| 59 | weekly+placebo-iv | 1 |
| 60 | work/school/other | 1 |
| 61 | zo-20 | 4 |
| 62 | €199/heifer | 1 |
| 63 | ≥0.79 | 1 |
| 1 | frames- | 1 |
| 2 | 187,000 | 3 |
| 3 | zo-20 | 4 |
| 4 | alfa/m2 | 1 |
| 5 | 4.9+/-7.3 | 1 |
| 6 | evasin-4 | 2 |
| 7 | 0.4+/-1.4 | 1 |
| 8 | 12,485 | 1 |
| 9 | pd-0299685 | 8 |
| 10 | ≥0.79 | 1 |
| 11 | pegylated-ifnα2a | 1 |
| 12 | rtifngamma | 7 |
| 13 | 2.5ata | 1 |
| 14 | county-specific | 2 |
| 15 | beta-carotene/d | 1 |
| 16 | rebandaged | 1 |
| 17 | adminitered | 1 |
| 18 | bid-based | 5 |
| 19 | nanorod-based | 1 |
| 20 | bid-treated | 1 |
| 21 | q4w-treated | 1 |
| 22 | bathroom-related | 1 |
| 23 | nurse-generated | 2 |
| 24 | 187-fold | 1 |
| 25 | 128-fold | 1 |
| 26 | once | 10,888 |
| 27 | daily-once | 1 |
| 28 | asprellanoside | 1 |
| 29 | nevirapine–zidovudine–lamivudine | 1 |
| 30 | binazine | 3 |
| 31 | methandrostenolone | 3 |
| 32 | 4.8g | 1 |
| 33 | 0.698g/kg | 1 |
| 34 | bolus/0.5-microg/kg | 1 |
| 35 | bolus/0.75-microg/kg | 1 |
| 36 | micron/kg | 1 |
| 37 | 500-1000mg | 1 |
| 38 | 40/10mg | 1 |
| 39 | 20lmg | 1 |
| 40 | tshre/l | 1 |
| 41 | dentifrice/dental | 1 |
| 42 | 0.063ng/ml | 1 |
| 43 | 0.19µg/ml | 1 |
| 44 | 50,000/µl | 1 |
| 45 | 80,000/µl | 1 |
| 46 | myomycin | 2 |
| 47 | sixin | 1 |
| 48 | 117/year | 1 |
| 49 | €199/heifer | 1 |
| 50 | work/school/other | 1 |
| 51 | dm-/chd-as | 1 |
| 52 | rich-foods | 1 |
| 53 | distance-is | 1 |
| 54 | soflens | 2 |
| 55 | call-ins | 1 |
| 56 | non-strenuous | 1 |
| 57 | polyphenol-content | 1 |
| 58 | weekly+placebo-iv | 1 |
| 59 | rosuvastatin/day | 1 |
| 60 | trimethoprim/sulphadiazine/kgbw/day | 1 |
| 61 | phasically | 1 |
| 62 | intra-cervically | 2 |
| 63 | anally | 1 |